Market Research Logo

Incontinence and Ostomy Care Global Market - Forecast to 2023

Incontinence and Ostomy Care Global Market - Forecast to 2023

Incontinence and ostomy care consist of products that are essential for patients with incontinence and stoma. With the projected rise in aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the incontinence and ostomy care global market is expected to grow at mid range single digit CAGR to reach $22,150.3 million by 2023. Factors driving the incontinence and ostomy care market include, increase in aging population, increase in awareness & use of personalized products are all contributing to the growth of incontinence and ostomy care global market. Alternative medical treatments, the presence of local manufacturers and low reimbursement are hampering the market growth. Advancement of technology with its wide application areas shows that incontinence and ostomy care market has vast opportunities in the coming years.

Incontinence and ostomy care global market is classified based on products, applications, end-users and geography. The products segment is divided into two segments i.e., incontinence care products and ostomy care products. Where, the incontinence care products are further classified into disposables (absorbents, incontinence bags, clamps and cleaners, deodorizers, urinals, anal irrigation systems, catheters, pessaries and others) and implants (sphincters, slings, sacral nerve stimulator and tibial nerve stimulator). While, the ostomy care market included products such as Ostomy bags, deodorants, skin barriers, irrigation products and others. Incontinence and ostomy care based on utility is classified into protection & cleansing, security & leakage, odor control and irrigation.

Based on application, the incontinence and ostomy care products is segmented into neurological conditions (multiple sclerosis, Parkinson’s disease), oncology (colorectal and prostate cancer), Urinogenital diseases, GI Tract diseases (Crohn's disease, Ulcerative colitis), women health related (childbirth and menopause) and others disease which include diarrhea, diabetes etc. Based on end users the market is segmented into hospitals, private clinics and home care.

Europe accounts for the highest market share followed by North America. The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of incontinence and ostomy care products market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for incontinence and ostomy care products.

Major players in Incontinence and ostomy care market include B. Braun Melsungen AG (Germany), Coloplast AG (Denmark), ConvaTec, Inc. (U.S.), Hollister Inc. (U.S.), Kimberly-Clark Corporation (U.S.), Medtronic, Inc. (Ireland), Salts Healthcare (U.K.), Svenska Cellulosa Aktiebolaget (Sweden), Unicharm Corporation (Japan), Paul Hartmann (Germany), Ontex (Belgium), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • U.K.
  • France
  • Others
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Middle-East
  • Others


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population
3.3.1.2 Development of innovative and personalized products
3.3.1.3 Increase in awareness and acceptance
3.3.1.4 Increase in prevalence of diseases
3.3.2 RESTRAINS AND THREATS
3.3.2.1 Environment and disposal concerns
3.3.2.2 Alternative medical treatment
3.3.2.3 Limited reimbursement
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 JAPAN
3.4.5 AUSTRALIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 CPT CODES
3.6 PATENT ANALYSIS
3.7 TECHNOLOGY ADVANCEMENTS
3.7.1 BIOMATERIAL ADVANCEMENTS
3.7.2 INCREASED ABSORBENCE
3.7.3 MOLDABLE TECHNOLOGY
3.7.4 NEXT GENERATION OSTOMY IMPLANTS
3.8 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH
3.9 CLINICAL TRIAL DATA
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 BARGAINING POWER OF SUPPLIERS
3.10.4 BARGAINING POWER OF BUYERS
3.10.5 RIVALRY AMONG EXISTING COMPETITORS
3.11 SUPPLY CHAIN ANALYSIS
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INCONTINENCE AND OSTOMY CARE PRODUCTS
4.2.1 INCONTINENCE CARE PRODUCTS
4.2.1.1 Disposable
4.2.1.1.1 Absorbent
4.2.1.1.1.1 Diapers
4.2.1.1.1.1.1 Pad type
4.2.1.1.1.1.2 Flat type
4.2.1.1.1.1.3 Others
4.2.1.1.1.2 Shields
4.2.1.1.2 Incontinence bags
4.2.1.1.3 Deodorizer
4.2.1.1.4 Clamps and cleaners
4.2.1.1.5 Urinals
4.2.1.1.6 Anal irrigation system
4.2.1.1.7 Incontinence catheter
4.2.1.1.8 Pessaries
4.2.1.1.9 Others
4.2.1.2 Implants
4.2.1.2.1 Sacral nerve stimulation (SNS)
4.2.1.2.2 Tibial nerve stimulation (TNS)
4.2.1.2.3 Sphincters
4.2.1.2.4 Slings
4.2.2 OSTOMY CARE PRODUCTS
4.2.2.1 Ostomy bags
4.2.2.1.1 One-piece ostomy bags
4.2.2.1.2 Two-piece ostomy bags
4.2.2.2 Skin barriers
4.2.2.3 Deodorants
4.2.2.4 Irrigation products
4.2.2.5 Other products
4.3 INCONTINENCE AND OSTOMY CARE PRODUCTS, BY UTILITY
4.3.1 INTRODUCTION
4.3.2 SECURITY AND LEAKAGE CONTROL
4.3.3 PROTECTION AND CLEANSING
4.3.4 ODOR CONTROL
4.3.5 IRRIGATION PRODUCTS
5 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET,
BY APPLICATIONS
5.1 INTRODUCTION
5.2 WOMEN HEALTH RELATED
5.3 GI TRACT DISEASES
5.4 ONCOLOGY
5.5 NEUROLOGICAL CONDITIONS
5.6 URINOGENITAL DISEASES
5.7 OTHERS
6 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET,
BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME CARE
6.4 PRIVATE CLINICS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 OTHERS
7.4 ASIA - PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 AUSTRALIA
7.4.4 OTHERS
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 MIDDLE EAST
7.5.3 OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 OTHERS
8.3 NEW PRODUCT LAUNCHES
8.4 AGREEMENTS, ACQUISITIONS & COLLABORATION
9 MAJOR COMPANIES
9.1 B.BRAUN MELSUNGEN AG
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 COLOPLAST
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 CONVATEC HEALTHCARE B S.A.R.L
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 HOLLISTER INCORPORATED
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 KIMBERLY-CLARK CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC, PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 ONTEX
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 PAUL HARTMANN AG
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 THE PROCTER & GAMBLE COMPANY
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 SALTS HEALTHCARE
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SVENSKA CELLULOSA AKTIEBOLAGET SCA
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 UNICHARM CORPORATION
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report